• calendar
  • globeLondon, UK

March 25-26, 2020

Scientific Programs

Keynote Presentation



Biography
Currently, he is the general director of Research Center in the Ministry of Health. Dr. Abdullah Alabdulgader is the Founder and Former Executive Director of Prince Sultan Cardiac Center, Al-Ahsa which is the major Cardiac Tertiary Center in the Eastern part of the Kingdom of Saudi Arabia and the Regional Cardiac referral for all cardiac-related diseases for all age groups. This center was found because of our efforts funded by the late Prince Sultan Abdulaziz and was able to establish a Research Administration within the center, with very strong link to KACST which is the national research fund agency in Kingdom of Saudi Arabia. In addition he is also the Founder and the Chief of the Research Team for International Project for Congenital Heart Disease (CHD) in the Kingdom of Saudi Arabia, G.C.C. Countries and in the Republic of Yemen. He has managed several projects/studies/researches in the past, not to mention the ongoing ones and with the more ambitious projects in the coming years which are directed to the benefits of the humanity. Currently, they are starting 2 major projects under the strategic planning of KACST which passed the American Agency for Advancements of Science (AAAS) evaluation with outstanding results. We are aiming very seriously to find therapeutic alternatives for degenerative diseases including cancer and atherosclerosis as well as discover genetic and environmental causes of Congenital Heart Diseases. Last but not least they are part of international group looking with eye of wisdom ,deep in the research of Bioelectric and frequency therapies which they believe is the future to treat chronic diseases including heart diseases.

Abstract
Since the dawn of human life, the innate perception of heart beat, being the source of life and the shine of the spirit that will depart only if the heart beating cease. The study of heart beat all over the time line of medicine from Galen and before to Ibn al-Nafis, and Ibn Sina passing to William Gilbert and his primitive attempts to record heart stimuli ending to Willem Einthoven who invented the modern ECG, was always concerned with the heart contraction. There was no clear perception of the importance of variation between heart beats or frequency bands associated with it. The understanding of Heart rate variability, defined as the change in the time intervals between adjacent heartbeats, is an emergent property of interdependent regulatory systems that operates on different time scales to adapt to environmental and psychophysiological Challenges. The importance of HRV as an index of the functional status of physiological control systems was noted only in 1965 when it was found that fetal distress is preceded by reductions in HRV before any changes occur in HR itself. The introduction of signal processing technologies that can acquire continuous time series data from physiological processes such as heart rate (HR), blood pressure (BP), and nerve activity, make it abundantly apparent that biological processes vary in complex and nonlinear ways, even during so called “steady-state” conditions [1]. This in our perspective is complementary but not competitive to the great physiologist Walter Bradford Cannon who expand Claude Bernard concept of homeostasis and the steady state condition that body cells, tissues and organs are strived to maintain. Healthy, optimal function as we perceive it in 2017 is the result of continuous, dynamic, bi-directional interactions among multiple neural, hormonal, and mechanical control systems at both local and central levels

Oral Presentation



Biography
Chao Wu, Female, 29 years old, attending physician, graduated from Fujian Medical University with a medical master's degree, is currently working in the First Department of Critical Care Medicine?Fujian Provincial Hospital South Branch, a national-level critical care center that treats thousands of critically ill patients every year. I have 4 years of clinical work experience in critical care medicine, specializing in fluid resuscitation, clinical hemodynamic therapy, bedside cardiac function assessment and treatment in critically ill patients, and has carried out a large number of studies. I have published several domestic articles and SCI articles.

Abstract
Introduction?Up to one-third of patients admitted to the ICU are in circulatory shock , early recognition of the condition is vital if subsequent tissue injuries are to be avoided. We would like to know what role the arterial lactic acid, Inferior vena cava diameter variability and CVP(central venous pressure) play in the early stages of shock. Methods: This is a retrospective study of patients who underwent surgical resuscitation in the Department of Critical Care Medicine . We use the ROC curve to evaluate the significance of each indicator in the diagnosis. For correlation analysis between groups, first use Linear regression to process and then analyze with Correlation. Results : The ROC curve analysis showed that the AUC of the lactic acid group was 0.9272, the AUC of the inferior vena cava variability group was 0.8652, the AUC of the CVP group was 0.633. Correlation analysis shows that the inferior vena cava variability and arterial lactic acid Persion r =0.2863. CVP and arterial lactic acid Persion r= 0.0729. Conclusion : The diagnostic value of arterial lactate is still very high, and can still be used as an early warning indicator to help clinicians be alert to the microcirculatory disorders that have emerged quietly . The degree of inferior vena cava variability is linearly related to arterial lactic acid, and can also be used as a reference indicator for early evaluation of shock . The diagnostic value of CVP is obviously lower.

Oral Presentation



Biography
Xiaobin Pan, Female, 29 years old, attending physician, graduated from Fujian Medical University with a medical master's degree, is currently working in the First Department of Critical Care Medicine?Fujian Provincial Hospital South Branch, a national-level critical care center that treats thousands of critically ill patients every year. I have 5 years of clinical work experience in critical care medicine, specializing in fluid resuscitation, clinical hemodynamic therapy, bedside cardiac function assessment and treatment in critically ill patients, and has carried out a large number of studies. I have published several domestic articles and SCI articles.

Abstract
Introduction?Up to one-third of patients admitted to the ICU are in circulatory shock , early recognition of the condition is vital if subsequent tissue injuries are to be avoided. We would like to know what role the arterial lactic acid, Inferior vena cava diameter variability and CVP(central venous pressure) play in the early stages of shock. Methods: This is a retrospective study of patients who underwent surgical resuscitation in the Department of Critical Care Medicine . We use the ROC curve to evaluate the significance of each indicator in the diagnosis. For correlation analysis between groups, first use Linear regression to process and then analyze with Correlation. Results : The ROC curve analysis showed that the AUC of the lactic acid group was 0.9272, the AUC of the inferior vena cava variability group was 0.8652, the AUC of the CVP group was 0.633. Correlation analysis shows that the inferior vena cava variability and arterial lactic acid Persion r =0.2863. CVP and arterial lactic acid Persion r= 0.0729. Conclusion : The diagnostic value of arterial lactate is still very high, and can still be used as an early warning indicator to help clinicians be alert to the microcirculatory disorders that have emerged quietly . The degree of inferior vena cava variability is linearly related to arterial lactic acid, and can also be used as a reference indicator for early evaluation of shock . The diagnostic value of CVP is obviously lower.

Oral Presentation



Biography
updated sooon...

Abstract
Overall objective: To describe the demographic, morbidity and indications for valvular heart valve surgery, operated with ON-X mechanical valves at the San Ignacio Hospital between 2006-2015. Describe the experience of the Hospital, the reasons for the surgeries and the evolution of these, with special emphasis on type and level of anticoagulation and complications. Methods: Descriptive observational study based on the surgical registry of the Cardiovascular Surgery service of San Ignacio Hospital during the years described. From this registry, the information was searched in the medical records of all patients treated at the Hospital during the period between 2006 and 2019, who received one or two ON-X mechanical valves, either due to an isolated valvular heart disease or for valvulopathy associated with another heart disease, such as ischemic heart disease. We excluded only incomplete medical records or those in which postoperative follow-up data could not be obtained. The data are useful to know the HUSI experience with ON-X mechanical valves and to compare, with the necessary precautions for population differences, with other similar institutions in Colombia and in world literature. Results: A total of 350 patients were taken at aortic or mitral valve exchange and received mechanical On-X prostheses. There was 30-day mortality in 40 patients given the high morbidity and complexity of procedures. At one year, 6 patients were added to mortality. Conclusions: The ON-X valves have shown advantages over other valves on the market, related to their structure, which decreases the pannus formation, and the results in relation to the PROACT study increase the interest for this type of valve. KEYWORDS Valvular heart disease, ON-X mechanical prosthetic valves, functionality, complications, anticoagulation, descriptive study.